KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Cash: 2017-2025

Historic Change in Cash for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$46.0 million.

  • Guardant Health's Change in Cash rose 86.75% to -$46.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 99.50%. This contributed to the annual value of -$503.9 million for FY2024, which is 150.81% down from last year.
  • As of Q3 2025, Guardant Health's Change in Cash stood at -$46.0 million, which was up 32.77% from -$68.4 million recorded in Q2 2025.
  • Guardant Health's Change in Cash's 5-year high stood at $676.3 million during Q4 2023, with a 5-year trough of -$358.3 million in Q2 2022.
  • For the 3-year period, Guardant Health's Change in Cash averaged around $49.8 million, with its median value being -$4.4 million (2024).
  • As far as peak fluctuations go, Guardant Health's Change in Cash crashed by 616.41% in 2022, and later surged by 4,158.59% in 2023.
  • Over the past 5 years, Guardant Health's Change in Cash (Quarterly) stood at -$340.4 million in 2021, then spiked by 95.10% to -$16.7 million in 2022, then spiked by 4,158.59% to $676.3 million in 2023, then slumped by 108.67% to -$58.6 million in 2024, then soared by 86.75% to -$46.0 million in 2025.
  • Its last three reported values are -$46.0 million in Q3 2025, -$68.4 million for Q2 2025, and $174.1 million during Q1 2025.